Bo Yu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- Renal and related cancers 5
-
- Lung Cancer Treatments and Mutations 10
- Renal cell carcinoma treatment 7
- Aortic Disease and Treatment Approaches 7
- Aortic aneurysm repair treatments 5
- Co-authors
- Qiu Rao (14 shared papers)Xiaojun Zhou (17 shared papers)Qiuyuan Xia (14 shared papers)Qun-Li Shi (13 shared papers)Biao Liu (13 shared papers)Qiong Du (2 shared papers)Qing Zhai (2 shared papers)Weihao Shi (11 shared papers)
- Journals
- Frontiers in Cardiovascular Medicine (3 papers)Histopathology (3 papers)OncoTargets and Therapy (2 papers)Human Pathology (2 papers)Ultrasound in Medicine & Biology (2 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Bo Yu
104 papers receiving 1.7k citations
Bo Yu's Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 314
- Oncology 367
- Pulmonary and Respiratory Medicine 391
- Molecular Biology 800
- Software 32
Countries citing papers authored by Bo Yu
This map shows the geographic impact of Bo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Yu more than expected).
Fields of papers citing papers by Bo Yu
This network shows the impact of papers produced by Bo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Yu. The network helps show where Bo Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 222 | |
| 2 | Using Cu‐Based Metal–Organic Framework as a Comprehensive and Powerful Antioxidant Nanozyme for Efficient Osteoarthritis Treatment Hit paper breakdown → | 2024 | 83 |
| 3 | 2021 | 66 | |
| 4 | 2017 | 65 | |
| 5 | 2012 | 60 | |
| 6 | 2012 | 60 | |
| 7 | Sirt3 attenuates doxorubicin-induced cardiac hypertrophy and mitochondrial dysfunction via suppression of Bnip3. | 2017 | 53 |
| 8 | 2017 | 51 | |
| 9 | 2004 | 46 | |
| 10 | 2014 | 44 | |
| 11 | 2021 | 39 | |
| 12 | 2008 | 39 | |
| 13 | Berberine regulates proliferation, collagen synthesis and cytokine secretion of cardiac fibroblasts via AMPK-mTOR-p70S6K signaling pathway. | 2015 | 33 |
| 14 | 2021 | 31 | |
| 15 | 2014 | 28 | |
| 16 | 2011 | 27 | |
| 17 | 2017 | 27 | |
| 18 | 2014 | 26 | |
| 19 | 2015 | 26 | |
| 20 | 2013 | 25 |
About Bo Yu
Bo Yu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Oncology and Surgery, having authored 111 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Renal cell carcinoma treatment (7 papers), Aortic Disease and Treatment Approaches (7 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), Atherosclerosis and Cardiovascular Diseases (5 papers), Renal and related cancers (5 papers) and Aortic aneurysm repair treatments (5 papers). The work is most often cited by research in Cancer Research (314 citations), Oncology (367 citations), Pulmonary and Respiratory Medicine (391 citations), Molecular Biology (800 citations) and Software (32 citations). Bo Yu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Qiu Rao, Xiaojun Zhou, Qiuyuan Xia, Qun-Li Shi, Biao Liu, Qiong Du, Qing Zhai, Weihao Shi, Zhenfeng Lu and Rusong Zhang. Their work appears in journals such as Frontiers in Cardiovascular Medicine, Histopathology, OncoTargets and Therapy, Human Pathology and Ultrasound in Medicine & Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.